Influence of Maternal Metabolic Status and Diet during the Perinatal Period on the Metabolic Programming by Leptin Ingested during the Suckling Period in Rats

Nutrients. 2023 Jan 21;15(3):570. doi: 10.3390/nu15030570.

Abstract

We aimed to analyze the long-term metabolic effects of leptin supplementation at physiological doses during suckling in the offspring of diet-induced obese rats, together with the potential benefits of improving maternal diet during lactation. Thus, the offspring of: dams fed standard-diet (SD) (CON-dams), dams fed western-diet (WD) before and during gestation and lactation (WD-dams), and dams fed as WD-dams but moved to SD during lactation (REV-dams) were supplemented throughout suckling with leptin or vehicle, and fed SD or WD from weaning to four months. Under SD, leptin treatment significantly improved metabolic profile and body fat accumulation, with stronger effects in the male offspring of CON-dams and REV-dams. Under WD, the offspring of WD-dams presented metabolic alterations that were not evident in the offspring of REV-dams. Moreover, leptin supplementation improved glucose homeostasis in the male offspring of REV-dams. Conversely, leptin supplementation in females born to WD-dams and fed WD from weaning resulted in impaired insulin sensitivity and increased hepatic lipid content. These results highlight the importance of a balanced maternal diet during the perinatal period, especially lactation, for the subsequent metabolic health of the offspring and for the beneficial effects of leptin supplementation during suckling, more evident in the male offspring.

Keywords: Western diet; lactation; leptin; metabolic programming.

MeSH terms

  • Adiposity
  • Animals
  • Diet
  • Female
  • Lactation
  • Leptin* / metabolism
  • Male
  • Maternal Nutritional Physiological Phenomena
  • Obesity / metabolism
  • Parturition
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Rats

Substances

  • Leptin

Grants and funding

This research was supported by Proyecto PGC2018-097436-B-I00, financed by MCIN/AEI/10.13039/501100011033/, and by “FEDER Una manera de hacer Europa”. The Research Group “Nutrigenomics, Biomarkers and Risk Evaluation” (NuBE) receives financial support from Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, CIBEROBN, and is a member of the European Research Network of Excellence NuGO (The European Nutrigenomics Organization, EU Contract: no. FP6-506360).